BIOBIJOU Co.,Ltd.

489460· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩13,280+0.84%

2026-11-02

Financials

Valuation Metrics

BIOBIJOU Co.,Ltd.'s Market Cap is ₩1959B. Ranked #812 of 2,410 in KR market (top 34%), #365 of 1,631 on KOSDAQ (top 22%), #89 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 39%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	195.92B KRW	KR#812/2,410 Sec#89/231
Revenue	28.49B KRW	KR#2,039/2,410 Sec#142/231
Net Income	4.15B KRW	KR#1,270/2,410 Sec#89/231
Total Assets	63.75B KRW	KR#2,066/2,410 Sec#178/231
Net Assets	61.98B KRW	KR#1,768/2,410 Sec#150/231
Value
P/E	47.19x	KR#1,414/2,410 Sec#90/231
P/B	3.16x	KR#2,158/2,410 Sec#174/231
P/S	6.88x	KR#2,227/2,410 Sec#154/231
EV/EBITDA	43.59x	KR#1,325/2,410 Sec#85/231
FCF Yield	-1.59%	KR—/2,410 Sec—/231
Profitability
ROE	6.70%	KR#917/2,410 Sec#63/231
ROA	6.51%	KR#570/2,410 Sec#45/231
Op. Margin	14.84%	KR#307/2,410 Sec#28/231
Financial Health
Debt Ratio	2.85%	KR#13/2,410 Sec#5/231
Total Debt	0 KRW	KR—/2,410 Sec—/231
FCF	-3.12B KRW	KR#1,394/2,410 Sec#110/231
Cash	11.64B KRW	KR#1,607/2,410 Sec#136/231
Current Ratio	30.20x	KR#10/2,410 Sec#5/231
Net Debt/EBITDA	-2.75x	KR#179/2,410 Sec#7/231
Dividend
Div. Yield	0.75%	KR#1,208/2,410 Sec#73/231
Performance
1Y Return	-14.10%	KR#960/2,410 Sec#60/231
1M Return	15.18%	KR#87/2,410 Sec#5/231
From 52W High	-17.46%	KR#152/2,410 Sec#8/231
1Y MDD	-65.04%	KR#1,718/2,410 Sec#146/231
Trading
Volume	59,669 shares	KR#1,243/2,410 Sec#125/231
Trading Value	773.9M KRW	KR#878/2,410 Sec#95/231
Foreign Own.	0.29%	KR#2,248/2,410 Sec#217/231
Per Share
EPS	281 KRW	KR#1,193/2,410 Sec#82/231
BPS	4,201 KRW	KR#1,641/2,410 Sec#119/231